The following is the latest information from federal regulators as of 4:45 p.m. on Thursday, April 9.
Centers for Medicare & Medicaid Services
See an updated list of the section 1135 waivers CMS has granted to help states and health care providers respond to the COVID-19 crisis.
National Institutes of Health
The NIH has announced the launch of a clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with COVID-19.
Department of Health and Human Services
- HHS has issued guidance that authorizes pharmacists to order and administer COVID-19 tests, including serology tests.
- The Department of Health and Human Services has published a notice in the Federal Register extending until June 21 the public comment period for addressing section 209 of the Pandemic and All-Hazards Preparedness and Advancing Technology Act.
- HHS has released a notice that will be published in the Federal Register explaining that it is exercising its discretion in how it applies HIPAA’s privacy, security, and breach notification rules in connection with good faith participation in the operation of COVID-19 community-based testing sites.
- HHS’s Administration for Community Living has announced that it will award $50 million in contracts to support efforts by Aging and Disability Resource Centers to prevent, prepare for, and respond to the COVID-19 crisis.
Food and Drug Administration
The FDA has published final guidance to health care professionals and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 and offers recommendations on the collection of COVID-19 convalescent plasma.